Format

Send to

Choose Destination
Epidemiology. 2017 Mar;28(2):233-236. doi: 10.1097/EDE.0000000000000598.

Improving Assessments of Population-level Vaccine Impact.

Author information

1
From the aDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT; bSage Analytica, Portland, ME; and cDepartment of Global Health, Milken Institute School of Public Health, George Washington University, Washington DC.
PMID:
27922531
PMCID:
PMC5285271
DOI:
10.1097/EDE.0000000000000598
[Indexed for MEDLINE]
Free PMC Article

Conflict of interest statement

RJT and LS have an ownership interest in Sage Analytica, a research consultancy. RJT, LS and CS have received support for other studies from investigator-initiated research grants from Pfizer to Sage Analytica. DMW has received research support for other studies from an investigator-initiated research grant from Pfizer to Yale University, and has received consulting fees from Merck.

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center